RT Journal Article
T1 Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
A1 Guerrero Orriach, Jose Luis
A1 Navarro Arce, I.
A1 Hernandez Rodriguez, P.
A1 Raigón Ponferrada, A.
A1 Malo Manso, A.
A1 Ramirez Aliaga, M.
A1 Ramirez Fernandez, A.
A1 Escalona Belmonte, J.J.
A1 Bellido Estevez, I.
A1 Gomez Luque, A.
A1 Barrera Serrano, R.
A1 Toledo Medina, C.S.
A1 Rubio Navarro, M.
A1 Cruz Mañas, J.
K1 Levosimendan
K1 Low cardiac output
K1 Kidney
K1 Cardiac surgery
K1 Simendán
K1 Gasto cardíaco bajo
K1 Riñón
K1 Cirugía torácica
AB Background: Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low cardiac output syndrome that seems to have a protective effect on renal function.Methods: It is a quasi-experimental study. A total of 100 patients with LCOS received either beta-agonists or levosimendan. We assessed the incidence of postoperative kidney failure in cardiac surgery patients. In patients who had kidney failure at diagnosis of LCOS, we examined whether differences existed in the evolution of kidney failure based on the treatment administered for LCOS. The parameters measured included haemodynamics, oxygen supply, and renal function as assessed by the AKI scale. ANOVA, Student's t-test and Wilcoxon or Friedman tests were used.Results: Up to 30% of cardiac surgery patients had kidney failure at diagnosis of LCOS. Kidney failure at discharge from the ICU was more frequent in patients who received beta-agonist drugs as compared to those who received levosimendan (p < 0.05).Conclusion: The incidence of kidney failure decreased with the postoperative administration of levosimendan to cardiac surgery patients with LCOS, as compared to beta-agonists.Trial registration: Current Controlled Trials ISRCTN 46058317. Date of registration: 7/10/2019. Retrospectively registered.
PB BioMed Central Ltd.
YR 2019
FD 2019-11-17
LK http://hdl.handle.net/10668/3193
UL http://hdl.handle.net/10668/3193
LA en
NO Guerrero Orriach JL, Navarro Arce I, Hernandez Rodriguez P, Raigón Ponferrada A, Malo Manso A, Ramirez Aliaga M, et al. Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists. BMC Anesthesiol. 2019 Nov 17;19(1):212.
DS RISalud
RD Apr 7, 2025